RecruitingNot ApplicableNCT06183281

Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity

Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity (INSPIRE): Tailored Digital Tools, Telehealth Coaching, and Primary Care Coordination


Sponsor

University of California, San Francisco

Enrollment

586 participants

Start Date

Apr 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023. A full two arm randomized controlled trial (RCT) will being in early 2025 with changes in PEG scores as the primary outcome. Secondary outcomes include Helping to End Addiction Longterm (HEAL) common data elements.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • age 18 or older
  • speak English, Spanish, or Cantonese
  • have a UCSF Health or SFHN medical provider (any type)
  • be willing to use a smartphone (iOS or Android - either their own or one provided by the study)
  • have chronic, non-malignant pain for at least 3 months
  • be willing to participate in a 12 month patient-centered chronic pain management study where they will be randomized into one of two comparison arms

Exclusion Criteria1

  • Severe mental illness or other condition preventing informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCBT, Mindfulness, and Movement

Blended CBT, mindfulness, and movement delivered through a mobile app and supported by a weekly telehealth pain management coach.


Locations(2)

San Francisco General Hospital

San Francisco, California, United States

UCSF Adult Primary Care Mt. Zion Clinic

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06183281


Related Trials